+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hospital Acquired Infection Control Market Research Report by Type, Pathogen Type, Indication, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 233 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 5454889
UP TO OFF until Dec 31st 2022
The Global Hospital Acquired Infection Control Market size was estimated at USD 30.34 billion in 2021, USD 32.09 billion in 2022, and is projected to grow at a CAGR of 5.93% to reach USD 42.89 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Hospital Acquired Infection Control to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Consumables, Disinfectants, Disinfectors, Endoscope Reprocessors, Infection Prevention & Surveillance Software, Microbial Testing Instruments, Others, Reagents, and Sterilizers.
  • Based on Pathogen Type, the market was studied across Bacterial, Fungal, and Viral.
  • Based on Indication, the market was studied across Bloodstream Infections, Gastrointestinal Infections, Hospital Acquired Pneumonia, Surgical Site Infections, and Urinary Tract Infections.
  • Based on End User, the market was studied across Ambulatory Surgical & Diagnostic Centers, Hospitals & ICUs, and Nursing Homes & Maternity Centers.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hospital Acquired Infection Control market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hospital Acquired Infection Control Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hospital Acquired Infection Control Market, including 3M Company, Abbott Laboratories, Advanced Sterilization Products Services Inc., Becton, Dickinson and Company, Belimed AG, BioMerieux SA, Cantel Medical Corporation, F. Hoffmann-La Roche Ltd, Kimberly-Clark Corporation, Merck & Co., Inc., Olympus Corporation, Pfizer Inc., Sterigenics International LLC., Steris Corporation, and Synergy Health, PLC.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Hospital Acquired Infection Control Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hospital Acquired Infection Control Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hospital Acquired Infection Control Market?
4. What is the competitive strategic window for opportunities in the Global Hospital Acquired Infection Control Market?
5. What are the technology trends and regulatory frameworks in the Global Hospital Acquired Infection Control Market?
6. What is the market share of the leading vendors in the Global Hospital Acquired Infection Control Market?
7. What modes and strategic moves are considered suitable for entering the Global Hospital Acquired Infection Control Market?
Frequently Asked Questions about the Global Hospital Acquired Infection Control Market

What is the estimated value of the Global Hospital Acquired Infection Control Market?

The Global Hospital Acquired Infection Control Market was estimated to be valued at $30.34 Billion in 2021.

What is the growth rate of the Global Hospital Acquired Infection Control Market?

The growth rate of the Global Hospital Acquired Infection Control Market is 5.9%, with an estimated value of $42.89 Billion by 2027.

What is the forecasted size of the Global Hospital Acquired Infection Control Market?

The Global Hospital Acquired Infection Control Market is estimated to be worth $42.89 Billion by 2027.

Who are the key companies in the Global Hospital Acquired Infection Control Market?

Key companies in the Global Hospital Acquired Infection Control Market include 3M Company, Abbott Laboratories, Advanced Sterilization Products Services Inc., Becton, Dickinson and Company, Belimed AG, BioMerieux SA, Cantel Medical Corporation, F. Hoffmann and Kimberly.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing geriatric population with the increase in the number of chronic diseases
5.1.1.2. Rapidly growing emphasis on infection control policies
5.1.1.3. Increasing use of disinfectors and medical nonwovens in the healthcare industry
5.1.2. Restraints
5.1.2.1. Lack of awareness regarding hospital acquired infection
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
5.1.3.2. Innovative technologies implemented in devices that control infection
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements
5.2. Cumulative Impact of COVID-19
6. Hospital Acquired Infection Control Market, by Type
6.1. Introduction
6.2. Consumables
6.3. Disinfectants
6.4. Disinfectors
6.5. Endoscope Reprocessors
6.6. Infection Prevention & Surveillance Software
6.7. Microbial Testing Instruments
6.8. Others
6.9. Reagents
6.10. Sterilizers
7. Hospital Acquired Infection Control Market, by Pathogen Type
7.1. Introduction
7.2. Bacterial
7.3. Fungal
7.4. Viral
8. Hospital Acquired Infection Control Market, by Indication
8.1. Introduction
8.2. Bloodstream Infections
8.3. Gastrointestinal Infections
8.4. Hospital Acquired Pneumonia
8.5. Surgical Site Infections
8.6. Urinary Tract Infections
9. Hospital Acquired Infection Control Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical & Diagnostic Centers
9.3. Hospitals & ICUs
9.4. Nursing Homes & Maternity Centers
10. Americas Hospital Acquired Infection Control Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Hospital Acquired Infection Control Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Hospital Acquired Infection Control Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. 3M Company
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Abbott Laboratories
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Advanced Sterilization Products Services Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Becton, Dickinson and Company
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Belimed AG
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. BioMerieux SA
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Cantel Medical Corporation
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. F. Hoffmann-La Roche Ltd
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Kimberly-Clark Corporation
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Merck & Co., Inc.
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Olympus Corporation
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Pfizer Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Sterigenics International LLC.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Steris Corporation
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Synergy Health, PLC
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET DYNAMICS
FIGURE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTORS, 2018-2027 (USD BILLION)
FIGURE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSORS, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INFECTION PREVENTION & SURVEILLANCE SOFTWARE, 2018-2027 (USD BILLION)
FIGURE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MICROBIAL TESTING INSTRUMENTS, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REAGENTS, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZERS, 2018-2027 (USD BILLION)
FIGURE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2021 VS 2027 (%)
FIGURE 24. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY PATHOGEN TYPE, 2027
FIGURE 26. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BACTERIAL, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY FUNGAL, 2018-2027 (USD BILLION)
FIGURE 28. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY VIRAL, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 30. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2027
FIGURE 32. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, 2018-2027 (USD BILLION)
FIGURE 33. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2027 (USD BILLION)
FIGURE 34. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, 2018-2027 (USD BILLION)
FIGURE 35. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2018-2027 (USD BILLION)
FIGURE 36. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, 2018-2027 (USD BILLION)
FIGURE 37. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 38. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 39. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 40. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, 2018-2027 (USD BILLION)
FIGURE 41. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, 2018-2027 (USD BILLION)
FIGURE 42. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, 2018-2027 (USD BILLION)
FIGURE 43. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 45. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 46. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 47. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 53. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 54. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 55. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 57. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 58. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 59. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 75. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 84. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 85. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 86. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 87. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 88. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 89. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 90. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 91. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 92. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 93. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 94. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 95. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 96. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 97. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 98. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTORS, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTORS, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTORS, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSORS, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSORS, BY REGION, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSORS, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INFECTION PREVENTION & SURVEILLANCE SOFTWARE, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INFECTION PREVENTION & SURVEILLANCE SOFTWARE, BY REGION, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INFECTION PREVENTION & SURVEILLANCE SOFTWARE, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MICROBIAL TESTING INSTRUMENTS, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MICROBIAL TESTING INSTRUMENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MICROBIAL TESTING INSTRUMENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY OTHERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REAGENTS, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REAGENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REAGENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 31. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZERS, 2018-2027 (USD BILLION)
TABLE 32. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 33. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 34. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 35. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BACTERIAL, 2018-2027 (USD BILLION)
TABLE 36. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 37. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 38. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY FUNGAL, 2018-2027 (USD BILLION)
TABLE 39. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY FUNGAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 40. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY FUNGAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 41. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY VIRAL, 2018-2027 (USD BILLION)
TABLE 42. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY VIRAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 43. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY VIRAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 44. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 45. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, 2018-2027 (USD BILLION)
TABLE 46. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 47. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 48. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2027 (USD BILLION)
TABLE 49. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 50. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 51. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, 2018-2027 (USD BILLION)
TABLE 52. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2018-2027 (USD BILLION)
TABLE 53. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2018-2027 (USD BILLION)
TABLE 54. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, 2018-2027 (USD BILLION)
TABLE 55. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 56. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 57. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, 2018-2027 (USD BILLION)
TABLE 58. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 59. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2027 (USD BILLION)
TABLE 60. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 61. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, 2018-2027 (USD BILLION)
TABLE 62. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 63. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 64. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, 2018-2027 (USD BILLION)
TABLE 65. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2018-2027 (USD BILLION)
TABLE 66. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2018-2027 (USD BILLION)
TABLE 67. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, 2018-2027 (USD BILLION)
TABLE 68. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 69. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2018-2027 (USD BILLION)
TABLE 70. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 71. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 72. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 73. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 74. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 75. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 76. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 77. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 78. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 79. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 80. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 81. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 82. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 83. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 84. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 85. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 86. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 87. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 88. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 89. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 90. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 91. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 92. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 93. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 94. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 95. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 96. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 97. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 98. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 99. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 100. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 101. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 102. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 103. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 104. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 105. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 106. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 107. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 108. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 109. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 110. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 111. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 112. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 113. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 114. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 115. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 116. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 117. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 118. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 119. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 120. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 121. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 122. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 123. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 124. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 125. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 126. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 127. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 128. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 129. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 130. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 131. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 132. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 133. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 134. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 135. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 136. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 137. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 138. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 139. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 140. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 141. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 142. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 143. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 144. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 145. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 146. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 147. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 148. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 149. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 150. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 151. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 152. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 153. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 154. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 155. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 156. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 157. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 158. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 159. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 160. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 161. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 162. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 163. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 164. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 165. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 166. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 167. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 174. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 175. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 176. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 177. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 178. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 179. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 180. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 181. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 182. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 183. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 184. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 185. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 186. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 187. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 188. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 189. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 190. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 191. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 192. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 193. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 194. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 195. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 196. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 197. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 198. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 199. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 200. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 201. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 202. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 203. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 204. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 205. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 206. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 207. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 208. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 209. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 210. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 211. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 212. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 213. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 214. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 215. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 216. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 217. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 218. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 219. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 220. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 221. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 222. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 223. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 224. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 225. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 226. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 227. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 228. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 229. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 230. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 231. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 232. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 233. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 234. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 235. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 236. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 237. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 238. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 239. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 240. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 241. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 242. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 243. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 244. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 245. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 246. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 247. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 248. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 249. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 250. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 251. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 252. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 253. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 254. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 255. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 256. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 257. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 258. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 259. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 260. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 261. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 262. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 263. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 264. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 265. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 266. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 267. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 268. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 269. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 270. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 271. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 272. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 273. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 274. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 275. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 276. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 277. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 278. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 279. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 280. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 281. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 282. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET RANKING, BY KEY PLAYER, 2021
TABLE 283. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2021
TABLE 284. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET MERGER & ACQUISITION
TABLE 285. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 286. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 287. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET INVESTMENT & FUNDING
TABLE 288. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 289. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET: LICENSE & PRICING

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Advanced Sterilization Products Services Inc.
  • Becton, Dickinson and Company
  • Belimed AG
  • BioMerieux SA
  • Cantel Medical Corporation
  • F. Hoffmann-La Roche Ltd
  • Kimberly-Clark Corporation
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer Inc.
  • Sterigenics International LLC.
  • Steris Corporation
  • Synergy Health, PLC

Methodology

Loading
LOADING...